Gefitinib: profile and news

Second Parkinson’s Drug, Requip, Blamed for Compulsive Gambling ... Feb 26, 2006
Now, however, a second drug has been thrust into the same spotlight with the filing of a $14 million lawsuit by a retired doctor who claims that Requip, a drug ... - Newsinferno.com,

Is there any way to treat restless legs syndrome? Mar 5, 2006
...first drug specifically marketed for restless leg syndrome, and earlier this year, Mayo Clinic researchers reported that the drug, Requip, can significantly ... - Boston Globe,

Requip eases restless legs, study confirms Feb 2, 2006
...large study confirms that restless legs syndrome (RLS) markedly reduces quality of life and interferes with sleep and that the drug Requip provides significant ... - Reuters

Restless legs syndrome an ache that keeps you awake Mar 3, 2006
...in the study of the RLS medication ropinirole. (It's now being marketed as Requip.). What causes restless legs syndrome is not clear ... - Fort Wayne News Sentinel,

EAR MALFUNCTION CAN SET THE WORLD SPINNING Mar 5, 2006
Requip (ropinirole) is the first medicine approved by the FDA for use in restless leg syndrome. Mirapex (pramipexole) is a closely related drug. ... - Charlotte Sun-Herald,

Gambler sues drugs giant for $15m loss Feb 25, 2006
Max Wells, 55, claims that GlaxoSmithKline failed to warn him that taking Requip, a medicine prescribed for Parkinson's disease, could cause compulsive ... - Telegraph.co.uk,

Doctor sues drug company, casinos after losing $14 million Feb 22, 2006
He declined to comment Tuesday. His lawsuit, filed Friday, says the drug company didn't warn patients that the drug Requip could cause compulsive behavior. ... - Oxford Press,

Retired Pathologist Sues Las Vegas Casinos and Drug Company after ... Feb 24, 2006
In his lawsuit, Wells claims that GlaxoSmithKline did not alert patients that the drug called Requip could potentially cause addictive behavior. ... - Big OC News

Tied to the Mast Feb 26, 2006
A (once)-wealthy retiree named Max Wells is suing GlaxoSmithKline over their Requip drug (ropinirole), claiming that he wasn't warned that the drug could cause ... - Corante,

Ispat holding firm seals Zimbabwe steel deal Mar 3, 2006
But since the 1990s, the company has been plagued by lack of capital to requip its plant and its annual production plummeted to nearly 80,000 tonne. ... - Business Standard,

DOC IN £8M DRUG GAMBLE Feb 23, 2006
...money back. He claims the company behind his prescribed medicine, Requip, didn't warn patients it could cause compulsive behaviour. - Glasgow Daily Record,

£8M 'BETS PILL' Feb 23, 2006
Max Wells, 55, is claiming drugs giant GlaxoSmithKline had failed to warn patients its medicine Requip can cause compulsive behaviour. ... - Mirror.co.uk,

Restless leg syndrome, pregnancy Feb 5, 2006
THIS STUDY randomly assigned 380 adults with restless legs and accompanying sleep disruption to take either ropinirole (Requip) or a placebo each night. ... - Seattle Times,

Analysis: Parkinsons patch helps symptoms Feb 27, 2006
In the study, 116 Parkinson's subjects were switched overnight to rotigotine from ropinirole -- sold as Requip -- pramipexole, or cabergoline, sold as Dostinex ... - United Press International

Boehringer Ingelheim receives positive opionion on Pramipexole ... Feb 24, 2006
...the first step in achieving Europe-wide marketing approval, and was approved by the US Food and Drug Administration in May, where it is sold as Requip. ... - Forbes

Gambler blames Parkinson's for his addiction Feb 24, 2006
Dr. Max Wells says the drug company failed to warn patients that Requip and a similar drug called Mirapex could cause compulsive gambling. ... - MSNBC

To sue or not to sue Feb 26, 2006
...gambling spree. His lawsuit asserts that the drug company didn't warn patients that the drug Requip could cause compulsive behavior. I ... - Zanesville Times Recorder,

Controlling Your Impulses After Parkinson's Treatment Feb 6, 2006
...variety of Parkinson's drugs have been linked to these side effects, the major culprit appears to be the so-called dopamine agonists, such as Requip and Mirapex ... - ABC News

Date Published: Wednesday, February 15th, 2006 Feb 15, 2006
When Mirapex, Requip, or another dopamine agonist is introduced, the behavioral changes in those adversely affected can be both quick and dramatic. ... - Newsinferno.com,

Study briefs, 01-31: Restless leg syndrome, colorectal cancer ... Jan 31, 2006
THIS STUDY randomly assigned 380 adults with restless legs and accompanying sleep disruption to take either ropinirole (Requip) or a placebo each night. ... - Lincoln Journal Star,

Restless Legs Syndrome: The most common neurological condition you ... Jan 11, 2006
Requip(r) (ropinirole HCl) Tablets, marketed by GlaxoSmithKline, is now the first and only treatment for patients with moderate-to-severe primary RLS. ... - El Dorado Times,

Exact cause of restless legs is unknown Jan 9, 2006
In more severe cases, medications may be necessary. RLS often is treated with medications known as nonergotamine agonists (such as Requip). ... - Newark Star Ledger,

Those restless legs Jan 15, 2006
Now, she said, symptoms occur about twice a week. "My doctor prescribed Requip, but I don't take it because it can cause sleepiness," said Brunot, who works as ... - Pittsburgh Tribune-Review,

New plan cuts many from meds Jan 21, 2006
But he's got a letter from pharmaceutical giant GlaxoSmithKline, which gives him Advair, Avandia and Requip through an assistance program. ... - Times Herald-Record,

GSW Worldwide/Junction 11 Receives One Silver and Three Awards of ... Dec 8, 2005
Junction 11 was honored with a Silver Award in the campaign category for the advertising campaign they created for GlaxoSmithKline's ReQuip, "Their lives in ... - PharmaLive.com (press release),

Wyeth’s President, Research & Development, Wyeth Pharmaceuticals ... Dec 9, 2005
...of a number of marketed products, including Dobutamine (Dobutrex) for the acute management of congestive heart failure, Ropinerole (Requip) for Parkinson's ... - PharmaLive.com (press release),

XenoPort Partners Asian Rights To Lead Product With Astellas Dec 1, 2005
Such a strategy was paved by May's approval of Requip (ropinirole, from GlaxoSmithKline plc), an event that better defined the restless legs syndrome patient ... - BioWorld Online (subscription),

GSW Worldwide's New York Office Announces New Hires Nov 28, 2005
...and Merck. Before FCB , he was an art director at TorreLazur-McCann, where he worked on GlaxoSmithKline's Requip RLS. Myers holds ... - PharmaLive.com (press release),

Last chance for a fix Nov 14, 2005
The absolute best one of late is an ad for Requip, a pill to treat Restless Legs Syndrome, or RLS. ... including Requip, have developed a problem with gambling. ... - Anchorage Daily News,

Restless leg syndrome tied to mental woes 31 Oct 2005
...pointed out. This past summer, FDA approved the dopamine agonist ropinirole (Requip) as first-line therapy for RLS. Phillips predicts ... - Reuters

Restless Legs Syndrome Causes Depression, Anxiety 31 Oct 2005
April 9, 2005 - The Food and Drug Administration has approved Requip (ropinirole) to treat moderate to severe Restless Legs Syndrome (RLS), an ailment that ... - SeniorJournal.com,

Funding enables choice to people with Parkinson's Oct 27, 2005
...between GlaxoSmithKline (GSK) and drug funding agency PHARMAC will allow people with Parkinson’s Disease funded access to Requip,™(ropinirole) which helps ... - Scoop.co.nz (press release),

Two more Parkinson's treatments to be subsidised Oct 27, 2005
Pharmac chief executive Wayne McNee said ropinirole (Requip) and entacapone (Comtan) provided alternatives to treatments that were already funded but could ... - Stuff.co.nz,

Two new treatments funded for Parkinson’s disease Oct 26, 2005
Ropinirole (Requip) and entacapone (Comtan) provide alternatives to treatments that are already funded, but which can cause serious side effects in some ... - Scoop.co.nz (press release),

Be still, my restless legs, I want to sleep Oct 23, 2005
Gabapentin is often prescribed for restless legs. If it doesn't work, there are other medicines that can be tried. The newest one is Requip. ... - Evansville Courier & Press (subscription),

HVB Keeps Schwarz Pharma At Outperform Oct 18, 2005
SRZ.XE) rotigotine drug for the treatment of restless legs syndrome indicate that it might be at least as efficacious as GlaxoSmithKlines' (GSK) Requip drug. ... - New Ratings

XenoPort is poised for growth after IPO Oct 2, 2005
However, in May, GlaxoSmithKline received FDA approval for an RLS drug called Requip. ... "We think our molecule has good attributes to compete with Requip. ... - San Jose Business Journal,

Disorder is a sleep thief Oct 25, 2005
...daily RLS. In May, the United States Food and Drug Administration approved the use of Requip, the first drug targeted for RLS. Other ... - The Journal News.com,

To treat shaking or restless legs, find the cause Oct 11, 2005
...than a year. Ropinirole (brand name Requip) has also recently been approved for use in treating restless leg syndrome. Treatment of ... - Newsday,

Boehringer's Pramipexole shown to be effective against restless ... Oct 17, 2005
...the first step in achieving Europe-wide marketing approval, and was approved by the US Food and Drug Administration in May, where it is sold as Requip. ... - Forbes

A few billion more: Glaxo considers doubling R&D spend Oct 1, 2005
Yamada is also excited about the recently launched Bonviva, for osteoporosis, and Requip, now approved for restless leg syndrome, which he said was a ... - The Sunday Times,

To treat shaking or restless legs, find the cause 11 Oct 2005
...than a year. Ropinirole (brand name Requip) has also recently been approved for use in treating restless leg syndrome. Treatment of ... - Newsday,

SkyePharma PLC (LSE: SKP; Nasdaq: SKYE) Announces Interim ... Sep 28, 2005
We have completed Phase III trials of Requip 24hr(TM), the once daily version of GlaxoSmithKline's Parkinson's drug Requip(R). The product is expected to be ... - PR Newswire (press release),

Study briefs, 9/20: Common drugs appear linked to bouts of ill ... Sep 20, 2005
Those who took drugs called dopamine agonists — including pramipexole (Mirapex), ropinirole (Requip) and pergolide (Permax) — were nearly three times more ... - Lincoln Journal Star,

GlaxoSmithKline says EU panel positive on Adartrel Sep 16, 2005
The drug is also marketed for the treatment of RLS under the name, Repreve, in Australia, and Requip in the United States. Ropinirole ... - MarketWatch

EU panel backs Glaxo restless leg syndrome drug Sep 15, 2005
The Committee for Medicinal Products for Human Use carried out an investigation into the product -- known by the brand names Requip and Adartrel -- after ... - Reuters